We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.86B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+3.16%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.6B
AUM Growth
+$48.1M
Cap. Flow
-$19.5M
Cap. Flow %
-0.75%
Top 10 Hldgs %
37.12%
Holding
232
New
10
Increased
45
Reduced
101
Closed
15

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$22.1M
2
SCHF icon
Schwab International Equity ETF
SCHF
+$14.7M
3
IBM icon
IBM
IBM
+$9.86M
4
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$9.81M
5
ORCL icon
Oracle
ORCL
+$9.2M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.5M
2
PEP icon
PepsiCo
PEP
+$12.1M
3
GILD icon
Gilead Sciences
GILD
+$9.61M
4
COL
Rockwell Collins
COL
+$4.97M
5
PG icon
Procter & Gamble
PG
+$4.81M

Sector Composition

Rank Sector Weight
1 Industrials 18.53%
2 Financials 16.35%
3 Communication Services 15.88%
4 Healthcare 13.72%
5 Consumer Staples 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VWO icon
151
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$494K 0.02%
11,332
-500
-4% -$21.6K
ADP icon
152
Automatic Data Processing
ADP
$108B
$485K 0.02%
4,436
CAG icon
153
Conagra Brands
CAG
$7.13B
$479K 0.02%
+14,200
New +$482K
ACN icon
154
Accenture
ACN
$109B
$478K 0.02%
3,539
+225
+7% +$29.3K
BX icon
155
Blackstone
BX
$111B
$478K 0.02%
14,335
+5,800
+68% +$191K
PPL
156
PPL Corp
PPL
$26.3B
$478K 0.02%
12,600
XLF icon
157
State Street Financial Select Sector SPDR ETF
XLF
$59B
$477K 0.02%
18,442
+520
+3% +$13K
NVO
158
Novo Nordisk
NVO
$209B
$463K 0.02%
19,250
-500
-3% -$11.3K
SO icon
159
Southern Company
SO
$105B
$456K 0.02%
9,278
EPD icon
160
Enterprise Products Partners
EPD
$81.8B
$442K 0.02%
16,938
-300
-2% -$7.93K
QCOM icon
161
Qualcomm
QCOM
$173B
$422K 0.02%
8,147
-3,790
-32% -$200K
DGX icon
162
Quest Diagnostics
DGX
$26.2B
$405K 0.02%
4,330
+330
+8% +$35K
SIVB
163
DELISTED
SVB Financial Group
SIVB
$393K 0.02%
2,100
OXY icon
164
Occidental Petroleum
OXY
$58B
$383K 0.01%
5,970
IWF icon
165
iShares Russell 1000 Growth ETF
IWF
$128B
$379K 0.01%
12,128
+3,320
+38% +$102K
CCL icon
166
Carnival Corporation Ltd
CCL
$38.7B
$372K 0.01%
5,750
+400
+7% +$26.7K
TGT icon
167
Target
TGT
$69.2B
$344K 0.01%
5,826
DVY icon
168
iShares Select Dividend ETF
DVY
$23.5B
$343K 0.01%
3,667
+1,467
+67% +$136K
BMO icon
169
Bank of Montreal
BMO
$128B
$330K 0.01%
4,364
DUK icon
170
Duke Energy
DUK
$94.9B
$323K 0.01%
3,846
DHR icon
171
Danaher
DHR
$145B
$319K 0.01%
4,191
+407
+11% +$30.1K
HFXE
172
DELISTED
IQ 50 Percent Hedged FTSE Europe ETF
HFXE
$319K 0.01%
16,000
ED icon
173
Consolidated Edison
ED
$39.3B
$316K 0.01%
3,920
BPL
174
DELISTED
Buckeye Partners, L.P.
BPL
$315K 0.01%
5,525
EXC icon
175
Exelon
EXC
$45.9B
$305K 0.01%
11,356
-246
-2% -$6.58K

Similar funds

Klingenstein Fields & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Klingenstein Fields & Co held 232 positions worth $2.6B, up 1.9% from $2.55B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Klingenstein Fields & Co's Q3 2017 filing shows 10 new, 45 increased, 101 reduced and 15 closed positions. Its largest new stake was Applied Materials: 11,560 shares worth $602K. The largest sale was Biogen, an estimated $16.5M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

  • Klingenstein Fields & Co's largest Q3 2017 buy was Applied Materials: 11,560 shares worth $602K.
  • Klingenstein Fields & Co added most to Intel in Q3 2017, an estimated $22.1M increase.
  • Klingenstein Fields & Co's biggest Q3 2017 reduction was PepsiCo, cutting an estimated $12.1M.
  • Klingenstein Fields & Co fully exited Biogen in Q3 2017, selling an estimated $16.5M.
  • Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.6B portfolio in Q3 2017.
  • Klingenstein Fields & Co opened 10 new positions and closed 15 in Q3 2017.
  • Klingenstein Fields & Co's portfolio value rose 1.9% quarter-over-quarter to $2.6B.

Based on Klingenstein Fields & Co's 13F filing for Q3 2017, filed 1 Nov 2017.